Symbolbild · KI-generiert
BIOSENTA Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
BIOSENTA Inc.'s line of retail anti-microbial products will effectively kill mould, bacteria and fungi on contact and prevent re-growth. These products address the demand created by the mounting health and environmental concerns. BIOSENTA will also manufacture and distribute an anti-microbial filler.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Industrials & Manufacturing sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| BIOSENTA Inc. | ZRO | CSE | 920.889 USD |
| Advantex Marketing International Inc. | ADX | CSE | 945.943 USD |
| Cloud3 Ventures Inc. | CLDV | CSE | 789.354 USD |
| Plaintree Systems Inc. | NPT | CSE | 737.122 USD |
| First Growth Funds Limited | FGFL | CSE | 1 Mio. USD |
| Doseology Sciences Inc | MOOD | CSE | 1 Mio. USD |
| Urban Infrastructure Group Inc. | UIG | TSXV | 1 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.